NASDAQ
Acumen Pharmaceuticals, Inc. (ABOS) has a current ratio of 4.07x as of Monday, May 25, 2026. This represents a 81.30% decrease compared to its 12-month average of 21.79x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.